Open House Drug Discount Agreements For The Active Ingredient Estradiol Atc G03Ca03

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566852

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Open House Drug Discount Agreements For The Active Ingredient Follitropin Alfa Atc G03Ga05

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566839

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Open House Drug Discount Agreements For The Active Ingredient Ganirelix Atc H01Cc01

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566835

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Open House Drug Discount Agreements For The Active Ingredient Lipegfilgrastim Atc L03Aa14

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566826

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Open House Drug Discount Agreements For The Active Ingredient Mebeverine Atc A03Aa04

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566822

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Open House Drug Discount Agreements For The Active Ingredient Tacrolimus Atc L04Ad02

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566816

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Open House Drug Discount Agreements For The Active Ingredient Pegfilgrastim Atc L03Aa13

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566808

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Open House Drug Discount Agreements For The Active Ingredient Doravirine Atc J05Ag06

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566804

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Open House Drug Discount Agreements For The Active Ingredients Bismuth Subcitrate Tetracycline And Metronidazole Atc A02Bd08

Deadline: 30 Apr 2028

Germany

Ref. No.: 27566791

EMD:Ref Document

Bid Value: Ref Document

608 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Etravirine Atc J05Ag04 For The Period July 1St 2026 June 30Th 2028

Deadline: 05 May 2028

Germany

Ref. No.: 27566735

EMD:Ref Document

Bid Value: Ref Document

613 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Propranolol Exclusively Dosage Form Lse Atc C07Aa05 For The Period July 1St 2026 June 30Th 2028

Deadline: 05 May 2028

Germany

Ref. No.: 27566668

EMD:Ref Document

Bid Value: Ref Document

613 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dornase Alfa Atc R05Cb13 For The Period July 1St 2026 June 30Th 2028

Deadline: 05 May 2028

Germany

Ref. No.: 27566665

EMD:Ref Document

Bid Value: Ref Document

613 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Ixekizumab Atc L04Ac13 For The Period July 1St 2026 June 30Th 2028

Deadline: 05 May 2028

Germany

Ref. No.: 27566660

EMD:Ref Document

Bid Value: Ref Document

613 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Piribedil Atc N04Bc08 For The Period July 1St 2026 June 30Th 2028

Deadline: 05 May 2028

Germany

Ref. No.: 27566652

EMD:Ref Document

Bid Value: Ref Document

613 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Denosumab Atc M05Bx04 For The Period July 1St 2026 June 30Th 2028 Plus Extension Option 1X12 Months

Deadline: 05 May 2029

Germany

Ref. No.: 27566642

EMD:Ref Document

Bid Value: Ref Document

978 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!